Fulcrum Therapeutics Enters into a Collaboration and License...
Fulcrum Therapeutics and Sanofi collaborate to commercialize Losmapimo
read more
Laboratory
Clinical Trial & Studies Updates
Avidity Announces data from phase 1/2 FORTITUDE™ trial
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2...